JP Morgan Chase’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Other funds holding BNGO
GCP
CAM
VCM
VFT
TSS
VF
JP Morgan Chase's BNGO Position: Q1 2026 in Review
JP Morgan Chase held its Bionano Genomics (BNGO) position steady in Q1 2026 at 11 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #7424.
JP Morgan Chase first reported a position in BNGO in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.27M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.
- JP Morgan Chase held 11 shares of Bionano Genomics worth $12 as of Q1 2026.
- JP Morgan Chase left its Bionano Genomics share count unchanged in Q1 2026.
- Bionano Genomics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7424 holding.
- JP Morgan Chase first reported a position in Bionano Genomics in Q3 2020 and has held it in 22 quarters since.
- JP Morgan Chase's Bionano Genomics position peaked at $1.27M in Q2 2021.
- 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.